Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review by Lianna Valdes, Jacob T. Cox, Janine Yang, Gayatri Susarla, Samuel Han, George N. Papaliodis, Lucia Sobrin

Subjects: Get full text

Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity by Kathleen P. Pratt

Subjects: “…anti-drug antibodies…”
Get full text

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers by Laine J, Jokiranta TS, Eklund KK, Väkeväinen M, Puolakka K

Subjects: Get full text

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases by Benucci M, Damiani A, Li Gobbi F, Bandinelli F, Infantino M, Grossi V, Manfredi M, Noguier G, Meacci F

Subjects: “…Anti-drug antibodies…”
Get full text

Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study by Pedersen L, Szecsi PB, Johansen PB, Bjerrum PJ

Subjects: Get full text

Anti-drug antibodies in Colombian patients with rheumatoid arthritis treated with Enbrel vs Etanar – Preliminary report by Benjamín Reyes-Beltrán, Gabriela Delgado

Subjects: Get full text

Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer by Yu. V. Medvedev, M. A. Kolganova, O. A. Sas, T. N. Komarov, E. N. Fisher, I. E. Shohin, Yu. I. Ammour

Subjects: Get full text

Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management by Katherine A. Kelly, Adaora Ewulu, Veronica K. Emmerich, Courtney E. Heron, Steven R. Feldman

Subjects: Get full text

Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum by M. A. Kolganova, O. S. Sagimbaeva, Ju. S. Borisova, E. E. Beketov, I. E. Shokhin

Subjects: Get full text

Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays by Xiaoliang Ding, Xiaoliang Ding, Ling Xue, Ling Xue, Mingjun Wang, Shengxiong Zhu, Shengxiong Zhu, Shengxiong Zhu, Kouzhu Zhu, Kouzhu Zhu, Kouzhu Zhu, Sheng Jiang, Sheng Jiang, Sheng Jiang, Jian Wu, Liyan Miao, Liyan Miao, Liyan Miao

Subjects: Get full text

Development and validation of an automated assay for anti-drug-antibodies in rat serum by Kristy A. Terrell, Gregory D. Sempowski, Andrew N. Macintyre

Subjects: “…Anti-drug antibodies (ADA)…”
Get full text

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers by Nebojsa Skorupan, Cody J. Peer, Xianyu Zhang, Hyoyoung Choo-Wosoba, Mehwish I. Ahmad, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Yunkai Yu, Guillaume Joe Pegna, Seth M. Steinberg, Shelley S. Kalsi, Liang Cao, William D. Figg, Jane B. Trepel, Ira Pastan, David FitzGerald, Christine Alewine

Subjects: Get full text

Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies’ Determination ag... by Francisco José Toja-Camba, Laura García-Quintanilla, Lorena Rodríguez-Martinez, Julia Tomine, Francisco Cajade-Pascual, Carolina Feitosa, Irene Zarra-Ferro, Manuel Barreiro-De-Acosta, Jaime González-López, Cristina Mondelo-García, Anxo Fernández-Ferreiro

Subjects: Get full text

Regulatory and strategic considerations for addressing immunogenicity and related responses in biopharmaceutical development programs by Tyler C. Vandivort, David B. Horton, Steven B. Johnson

Subjects: Get full text

Therapeutic proteins immunogenicity: a peptide point of view by Feliciana Real-Fernandez, Fosca Errante, Andrea Di Santo, Anna Maria Papini, Paolo Rovero

Subjects: Get full text

Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies by Maria U. Johansson, Christopher Weinert, Dietrich Alexander Reichardt, Dana Mahler, Dania Diem, Christian Hess, Diana Feusi, Simon Carnal, Julia Tietz, Noreen Giezendanner, Fabio Mario Spiga, David Urech, Stefan Warmuth

Subjects: “…Anti-drug antibodies…”
Get full text

Immunogenicity of anti-TNF-α biotherapies.I. Individualized medicine based on immunopharmacological evidence by Klaus eBendtzen

Subjects: Get full text

The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity by Wojciech Jankowski, Christopher Kidchob, Campbell Bunce, Edward Cloake, Ricardo Resende, Zuben E. Sauna

Subjects: Get full text

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ by Kirsty E. Waddington, Kirsty E. Waddington, Artemis Papadaki, Leda Coelewij, Leda Coelewij, Marsilio Adriani, Petra Nytrova, Eva Kubala Havrdova, Anna Fogdell-Hahn, Rachel Farrell, Pierre Dönnes, Pierre Dönnes, Inés Pineda-Torra, Elizabeth C. Jury

Subjects: Get full text

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies by Anna Vaisman-Mentesh, Matias Gutierrez-Gonzalez, Brandon J. DeKosky, Brandon J. DeKosky, Yariv Wine

Subjects: Get full text